2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$7.84-$0.005 (-0.06%)
Price as of Sep 11, 2026 7:32 PM EDT- $517.8MMarket Cap
- 9.04%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$7.84-$0.005 (-0.06%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.84 | ||
Change | -$0.07 (-0.88%) | ||
Open | $8.01 | ||
High | $8.15 | ||
Low | $7.81 | ||
Previous Close | $7.91 | ||
Volume | 586,591 | ||
30-Day Average Volume | 961,462 | ||
1-Week Change | -15.70% | ||
1-Month Change | -6.00% | ||
1-Year Change | 9.04% | ||
3-Year Change | -17.91% | ||
5-Year Change | -3.33% | ||
Fundamentals | |||
Shares Outstanding | 66.1M | ||
Total Assets | $248.0M | ||
Market Cap | $517.8M | ||
Enterprise Value | $629.4M | ||
Period: QTR TTM FY | |||
Revenue | $83.3M | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$8.2M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -107 | ||
Enterprise Value/Revenue | 8 | ||
P/B | -17 | ||
P/E | -65 | ||
PEG | -3 | ||
Price/Free Cash Flow | -142 | ||
Price/Operating Cash Flow | -144 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue